 | • レポートコード：MRC2-11QY04331 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は術後悪心嘔吐（PONV）のグローバル市場について調査・分析したレポートです。種類別（セロトニン拮抗薬、ステロイド、ドーパミン拮抗薬、NK-1受容体拮抗薬、その他、非薬理学的治療）市場規模、用途別（病院薬局、オンライン薬局、小売薬局、ドラッグストア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別術後悪心嘔吐（PONV）の競争状況、市場シェア ・世界の術後悪心嘔吐（PONV）市場：種類別市場規模 2015年-2020年（セロトニン拮抗薬、ステロイド、ドーパミン拮抗薬、NK-1受容体拮抗薬、その他、非薬理学的治療） ・世界の術後悪心嘔吐（PONV）市場：種類別市場規模予測 2021年-2026年（セロトニン拮抗薬、ステロイド、ドーパミン拮抗薬、NK-1受容体拮抗薬、その他、非薬理学的治療） ・世界の術後悪心嘔吐（PONV）市場：用途別市場規模 2015年-2020年（病院薬局、オンライン薬局、小売薬局、ドラッグストア） ・世界の術後悪心嘔吐（PONV）市場：用途別市場規模予測 2021年-2026年（病院薬局、オンライン薬局、小売薬局、ドラッグストア） ・北米の術後悪心嘔吐（PONV）市場分析：米国、カナダ ・ヨーロッパの術後悪心嘔吐（PONV）市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの術後悪心嘔吐（PONV）市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の術後悪心嘔吐（PONV）市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの術後悪心嘔吐（PONV）市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Acacia Pharma、F. Hoffmann-La Roche、Novartis、Ani Pharmaceuticals、Camurus、Sanofi、Helsinn Holding、Eisai、Merck、GlaxoSmithKline ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
The global post-operative nausea and vomiting (PONV) market is growing at a significant rate due to bourgeoning incidence rate of post-operative complications and increasing demand for combination therapy, as well as introduction of promising drugs in this segment across the globe.
Major factors boosting the growth of the post-operative nausea and vomiting market include large number of surgeries performed and rise in the rate of postoperative complications, such as, dizziness, vomiting, and nausea. However, strict regulatory approvals and high health care expenditure are predicted to hamper the growth of the PONV market during the forecast period.
Market Analysis and Insights: Global Postoperative Nausea and Vomiting (PONV) Market
The global Postoperative Nausea and Vomiting (PONV) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Postoperative Nausea and Vomiting (PONV) Scope and Market Size
Postoperative Nausea and Vomiting (PONV) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Postoperative Nausea and Vomiting (PONV) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Acacia Pharma
F. Hoffmann-La Roche
Novartis
Ani Pharmaceuticals
Camurus
Sanofi
Helsinn Holding
Eisai
Merck
GlaxoSmithKline
Market segment by Type, the product can be split into
Serotonin Antagonists
Steroids
Dopamine Antagonists
NK-1 Receptor Antagonists
Others
Non-pharmacologic Treatment
Market segment by Application, split into
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies and Drug Stores
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Postoperative Nausea and Vomiting (PONV) Revenue
1.4 Market by Type
1.4.1 Global Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Serotonin Antagonists
1.4.3 Steroids
1.4.4 Dopamine Antagonists
1.4.5 NK-1 Receptor Antagonists
1.4.6 Others
1.4.7 Non-pharmacologic Treatment
1.5 Market by Application
1.5.1 Global Postoperative Nausea and Vomiting (PONV) Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Online Pharmacies
1.5.4 Retail Pharmacies and Drug Stores
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Postoperative Nausea and Vomiting (PONV) Market Perspective (2015-2026)
2.2 Global Postoperative Nausea and Vomiting (PONV) Growth Trends by Regions
2.2.1 Postoperative Nausea and Vomiting (PONV) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Postoperative Nausea and Vomiting (PONV) Historic Market Share by Regions (2015-2020)
2.2.3 Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Postoperative Nausea and Vomiting (PONV) Market Growth Strategy
2.3.6 Primary Interviews with Key Postoperative Nausea and Vomiting (PONV) Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Postoperative Nausea and Vomiting (PONV) Players by Market Size
3.1.1 Global Top Postoperative Nausea and Vomiting (PONV) Players by Revenue (2015-2020)
3.1.2 Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Players (2015-2020)
3.1.3 Global Postoperative Nausea and Vomiting (PONV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Postoperative Nausea and Vomiting (PONV) Market Concentration Ratio
3.2.1 Global Postoperative Nausea and Vomiting (PONV) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Postoperative Nausea and Vomiting (PONV) Revenue in 2019
3.3 Postoperative Nausea and Vomiting (PONV) Key Players Head office and Area Served
3.4 Key Players Postoperative Nausea and Vomiting (PONV) Product Solution and Service
3.5 Date of Enter into Postoperative Nausea and Vomiting (PONV) Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Postoperative Nausea and Vomiting (PONV) Historic Market Size by Type (2015-2020)
4.2 Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Postoperative Nausea and Vomiting (PONV) Market Size by Application (2015-2020)
5.2 Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Postoperative Nausea and Vomiting (PONV) Market Size (2015-2020)
6.2 Postoperative Nausea and Vomiting (PONV) Key Players in North America (2019-2020)
6.3 North America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2015-2020)
6.4 North America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2015-2020)
7 Europe
7.1 Europe Postoperative Nausea and Vomiting (PONV) Market Size (2015-2020)
7.2 Postoperative Nausea and Vomiting (PONV) Key Players in Europe (2019-2020)
7.3 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Type (2015-2020)
7.4 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Application (2015-2020)
8 China
8.1 China Postoperative Nausea and Vomiting (PONV) Market Size (2015-2020)
8.2 Postoperative Nausea and Vomiting (PONV) Key Players in China (2019-2020)
8.3 China Postoperative Nausea and Vomiting (PONV) Market Size by Type (2015-2020)
8.4 China Postoperative Nausea and Vomiting (PONV) Market Size by Application (2015-2020)
9 Japan
9.1 Japan Postoperative Nausea and Vomiting (PONV) Market Size (2015-2020)
9.2 Postoperative Nausea and Vomiting (PONV) Key Players in Japan (2019-2020)
9.3 Japan Postoperative Nausea and Vomiting (PONV) Market Size by Type (2015-2020)
9.4 Japan Postoperative Nausea and Vomiting (PONV) Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Postoperative Nausea and Vomiting (PONV) Market Size (2015-2020)
10.2 Postoperative Nausea and Vomiting (PONV) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Postoperative Nausea and Vomiting (PONV) Market Size by Type (2015-2020)
10.4 Southeast Asia Postoperative Nausea and Vomiting (PONV) Market Size by Application (2015-2020)
11 India
11.1 India Postoperative Nausea and Vomiting (PONV) Market Size (2015-2020)
11.2 Postoperative Nausea and Vomiting (PONV) Key Players in India (2019-2020)
11.3 India Postoperative Nausea and Vomiting (PONV) Market Size by Type (2015-2020)
11.4 India Postoperative Nausea and Vomiting (PONV) Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Postoperative Nausea and Vomiting (PONV) Market Size (2015-2020)
12.2 Postoperative Nausea and Vomiting (PONV) Key Players in Central & South America (2019-2020)
12.3 Central & South America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2015-2020)
12.4 Central & South America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Acacia Pharma
13.1.1 Acacia Pharma Company Details
13.1.2 Acacia Pharma Business Overview
13.1.3 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Introduction
13.1.4 Acacia Pharma Revenue in Postoperative Nausea and Vomiting (PONV) Business (2015-2020))
13.1.5 Acacia Pharma Recent Development
13.2 F. Hoffmann-La Roche
13.2.1 F. Hoffmann-La Roche Company Details
13.2.2 F. Hoffmann-La Roche Business Overview
13.2.3 F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Introduction
13.2.4 F. Hoffmann-La Roche Revenue in Postoperative Nausea and Vomiting (PONV) Business (2015-2020)
13.2.5 F. Hoffmann-La Roche Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview
13.3.3 Novartis Postoperative Nausea and Vomiting (PONV) Introduction
13.3.4 Novartis Revenue in Postoperative Nausea and Vomiting (PONV) Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 Ani Pharmaceuticals
13.4.1 Ani Pharmaceuticals Company Details
13.4.2 Ani Pharmaceuticals Business Overview
13.4.3 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Introduction
13.4.4 Ani Pharmaceuticals Revenue in Postoperative Nausea and Vomiting (PONV) Business (2015-2020)
13.4.5 Ani Pharmaceuticals Recent Development
13.5 Camurus
13.5.1 Camurus Company Details
13.5.2 Camurus Business Overview
13.5.3 Camurus Postoperative Nausea and Vomiting (PONV) Introduction
13.5.4 Camurus Revenue in Postoperative Nausea and Vomiting (PONV) Business (2015-2020)
13.5.5 Camurus Recent Development
13.6 Sanofi
13.6.1 Sanofi Company Details
13.6.2 Sanofi Business Overview
13.6.3 Sanofi Postoperative Nausea and Vomiting (PONV) Introduction
13.6.4 Sanofi Revenue in Postoperative Nausea and Vomiting (PONV) Business (2015-2020)
13.6.5 Sanofi Recent Development
13.7 Helsinn Holding
13.7.1 Helsinn Holding Company Details
13.7.2 Helsinn Holding Business Overview
13.7.3 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Introduction
13.7.4 Helsinn Holding Revenue in Postoperative Nausea and Vomiting (PONV) Business (2015-2020)
13.7.5 Helsinn Holding Recent Development
13.8 Eisai
13.8.1 Eisai Company Details
13.8.2 Eisai Business Overview
13.8.3 Eisai Postoperative Nausea and Vomiting (PONV) Introduction
13.8.4 Eisai Revenue in Postoperative Nausea and Vomiting (PONV) Business (2015-2020)
13.8.5 Eisai Recent Development
13.9 Merck
13.9.1 Merck Company Details
13.9.2 Merck Business Overview
13.9.3 Merck Postoperative Nausea and Vomiting (PONV) Introduction
13.9.4 Merck Revenue in Postoperative Nausea and Vomiting (PONV) Business (2015-2020)
13.9.5 Merck Recent Development
13.10 GlaxoSmithKline
13.10.1 GlaxoSmithKline Company Details
13.10.2 GlaxoSmithKline Business Overview
13.10.3 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Introduction
13.10.4 GlaxoSmithKline Revenue in Postoperative Nausea and Vomiting (PONV) Business (2015-2020)
13.10.5 GlaxoSmithKline Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Postoperative Nausea and Vomiting (PONV) Key Market Segments
Table 2. Key Players Covered: Ranking by Postoperative Nausea and Vomiting (PONV) Revenue
Table 3. Ranking of Global Top Postoperative Nausea and Vomiting (PONV) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Serotonin Antagonists
Table 6. Key Players of Steroids
Table 7. Key Players of Dopamine Antagonists
Table 8. Key Players of NK-1 Receptor Antagonists
Table 9. Key Players of Others
Table 10. Key Players of Non-pharmacologic Treatment
Table 11. Global Postoperative Nausea and Vomiting (PONV) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Postoperative Nausea and Vomiting (PONV) Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Postoperative Nausea and Vomiting (PONV) Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Postoperative Nausea and Vomiting (PONV) Market Share by Regions (2015-2020)
Table 15. Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Postoperative Nausea and Vomiting (PONV) Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Postoperative Nausea and Vomiting (PONV) Market Growth Strategy
Table 21. Main Points Interviewed from Key Postoperative Nausea and Vomiting (PONV) Players
Table 22. Global Postoperative Nausea and Vomiting (PONV) Revenue by Players (2015-2020) (Million US$)
Table 23. Global Postoperative Nausea and Vomiting (PONV) Market Share by Players (2015-2020)
Table 24. Global Top Postoperative Nausea and Vomiting (PONV) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Postoperative Nausea and Vomiting (PONV) as of 2019)
Table 25. Global Postoperative Nausea and Vomiting (PONV) by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Postoperative Nausea and Vomiting (PONV) Product Solution and Service
Table 28. Date of Enter into Postoperative Nausea and Vomiting (PONV) Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Postoperative Nausea and Vomiting (PONV) Market Size by Type (2015-2020) (Million US$)
Table 31. Global Postoperative Nausea and Vomiting (PONV) Market Size Share by Type (2015-2020)
Table 32. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Type (2021-2026)
Table 33. Global Postoperative Nausea and Vomiting (PONV) Market Size Share by Application (2015-2020)
Table 34. Global Postoperative Nausea and Vomiting (PONV) Market Size by Application (2015-2020) (Million US$)
Table 35. Global Postoperative Nausea and Vomiting (PONV) Market Size Share by Application (2021-2026)
Table 36. North America Key Players Postoperative Nausea and Vomiting (PONV) Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Postoperative Nausea and Vomiting (PONV) Market Share (2019-2020)
Table 38. North America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2015-2020) (Million US$)
Table 39. North America Postoperative Nausea and Vomiting (PONV) Market Share by Type (2015-2020)
Table 40. North America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2015-2020) (Million US$)
Table 41. North America Postoperative Nausea and Vomiting (PONV) Market Share by Application (2015-2020)
Table 42. Europe Key Players Postoperative Nausea and Vomiting (PONV) Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Postoperative Nausea and Vomiting (PONV) Market Share (2019-2020)
Table 44. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Postoperative Nausea and Vomiting (PONV) Market Share by Type (2015-2020)
Table 46. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Postoperative Nausea and Vomiting (PONV) Market Share by Application (2015-2020)
Table 48. China Key Players Postoperative Nausea and Vomiting (PONV) Revenue (2019-2020) (Million US$)
Table 49. China Key Players Postoperative Nausea and Vomiting (PONV) Market Share (2019-2020)
Table 50. China Postoperative Nausea and Vomiting (PONV) Market Size by Type (2015-2020) (Million US$)
Table 51. China Postoperative Nausea and Vomiting (PONV) Market Share by Type (2015-2020)
Table 52. China Postoperative Nausea and Vomiting (PONV) Market Size by Application (2015-2020) (Million US$)
Table 53. China Postoperative Nausea and Vomiting (PONV) Market Share by Application (2015-2020)
Table 54. Japan Key Players Postoperative Nausea and Vomiting (PONV) Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Postoperative Nausea and Vomiting (PONV) Market Share (2019-2020)
Table 56. Japan Postoperative Nausea and Vomiting (PONV) Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Postoperative Nausea and Vomiting (PONV) Market Share by Type (2015-2020)
Table 58. Japan Postoperative Nausea and Vomiting (PONV) Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Postoperative Nausea and Vomiting (PONV) Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Postoperative Nausea and Vomiting (PONV) Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Postoperative Nausea and Vomiting (PONV) Market Share (2019-2020)
Table 62. Southeast Asia Postoperative Nausea and Vomiting (PONV) Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Postoperative Nausea and Vomiting (PONV) Market Share by Type (2015-2020)
Table 64. Southeast Asia Postoperative Nausea and Vomiting (PONV) Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Postoperative Nausea and Vomiting (PONV) Market Share by Application (2015-2020)
Table 66. India Key Players Postoperative Nausea and Vomiting (PONV) Revenue (2019-2020) (Million US$)
Table 67. India Key Players Postoperative Nausea and Vomiting (PONV) Market Share (2019-2020)
Table 68. India Postoperative Nausea and Vomiting (PONV) Market Size by Type (2015-2020) (Million US$)
Table 69. India Postoperative Nausea and Vomiting (PONV) Market Share by Type (2015-2020)
Table 70. India Postoperative Nausea and Vomiting (PONV) Market Size by Application (2015-2020) (Million US$)
Table 71. India Postoperative Nausea and Vomiting (PONV) Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Postoperative Nausea and Vomiting (PONV) Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Postoperative Nausea and Vomiting (PONV) Market Share (2019-2020)
Table 74. Central & South America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Postoperative Nausea and Vomiting (PONV) Market Share by Type (2015-2020)
Table 76. Central & South America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Postoperative Nausea and Vomiting (PONV) Market Share by Application (2015-2020)
Table 78. Acacia Pharma Company Details
Table 79. Acacia Pharma Business Overview
Table 80. Acacia Pharma Product
Table 81. Acacia Pharma Revenue in Postoperative Nausea and Vomiting (PONV) Business (2015-2020) (Million US$)
Table 82. Acacia Pharma Recent Development
Table 83. F. Hoffmann-La Roche Company Details
Table 84. F. Hoffmann-La Roche Business Overview
Table 85. F. Hoffmann-La Roche Product
Table 86. F. Hoffmann-La Roche Revenue in Postoperative Nausea and Vomiting (PONV) Business (2015-2020) (Million US$)
Table 87. F. Hoffmann-La Roche Recent Development
Table 88. Novartis Company Details
Table 89. Novartis Business Overview
Table 90. Novartis Product
Table 91. Novartis Revenue in Postoperative Nausea and Vomiting (PONV) Business (2015-2020) (Million US$)
Table 92. Novartis Recent Development
Table 93. Ani Pharmaceuticals Company Details
Table 94. Ani Pharmaceuticals Business Overview
Table 95. Ani Pharmaceuticals Product
Table 96. Ani Pharmaceuticals Revenue in Postoperative Nausea and Vomiting (PONV) Business (2015-2020) (Million US$)
Table 97. Ani Pharmaceuticals Recent Development
Table 98. Camurus Company Details
Table 99. Camurus Business Overview
Table 100. Camurus Product
Table 101. Camurus Revenue in Postoperative Nausea and Vomiting (PONV) Business (2015-2020) (Million US$)
Table 102. Camurus Recent Development
Table 103. Sanofi Company Details
Table 104. Sanofi Business Overview
Table 105. Sanofi Product
Table 106. Sanofi Revenue in Postoperative Nausea and Vomiting (PONV) Business (2015-2020) (Million US$)
Table 107. Sanofi Recent Development
Table 108. Helsinn Holding Company Details
Table 109. Helsinn Holding Business Overview
Table 110. Helsinn Holding Product
Table 111. Helsinn Holding Revenue in Postoperative Nausea and Vomiting (PONV) Business (2015-2020) (Million US$)
Table 112. Helsinn Holding Recent Development
Table 113. Eisai Business Overview
Table 114. Eisai Product
Table 115. Eisai Company Details
Table 116. Eisai Revenue in Postoperative Nausea and Vomiting (PONV) Business (2015-2020) (Million US$)
Table 117. Eisai Recent Development
Table 118. Merck Company Details
Table 119. Merck Business Overview
Table 120. Merck Product
Table 121. Merck Revenue in Postoperative Nausea and Vomiting (PONV) Business (2015-2020) (Million US$)
Table 122. Merck Recent Development
Table 123. GlaxoSmithKline Company Details
Table 124. GlaxoSmithKline Business Overview
Table 125. GlaxoSmithKline Product
Table 126. GlaxoSmithKline Revenue in Postoperative Nausea and Vomiting (PONV) Business (2015-2020) (Million US$)
Table 127. GlaxoSmithKline Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Postoperative Nausea and Vomiting (PONV) Market Share by Type: 2020 VS 2026
Figure 2. Serotonin Antagonists Features
Figure 3. Steroids Features
Figure 4. Dopamine Antagonists Features
Figure 5. NK-1 Receptor Antagonists Features
Figure 6. Others Features
Figure 7. Non-pharmacologic Treatment Features
Figure 8. Global Postoperative Nausea and Vomiting (PONV) Market Share by Application: 2020 VS 2026
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Retail Pharmacies and Drug Stores Case Studies
Figure 12. Postoperative Nausea and Vomiting (PONV) Report Years Considered
Figure 13. Global Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Postoperative Nausea and Vomiting (PONV) Market Share by Regions: 2020 VS 2026
Figure 15. Global Postoperative Nausea and Vomiting (PONV) Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Postoperative Nausea and Vomiting (PONV) Market Share by Players in 2019
Figure 18. Global Top Postoperative Nausea and Vomiting (PONV) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Postoperative Nausea and Vomiting (PONV) as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Postoperative Nausea and Vomiting (PONV) Revenue in 2019
Figure 20. North America Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
化学療法誘発性悪心・嘔吐（CINV）の世界市場（～2026年） Chemotherapy-Induced Nausea and Vomiting (CINV) is one of the devastating side effects for patients undergoing cancer treatment. It is caused when various types of poisonous substances such as chemotherapeutic agents enter in the human body and alert the digestive system during chemotherapy. Besides…- 化学療法誘発性悪心・嘔吐（CINV）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market The global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Chemoth…
- 吐き気薬の世界市場（～2026年） Nausea is an unpleasant, diffuse sensation of unease and discomfort, often perceived as an urge to vomit. While not painful, it can be a debilitating symptom if prolonged, and has been described as placing discomfort on the chest, upper abdomen, or back of the throat. Many pharmacologic medications …
- セロトニン拮抗薬の世界市場（～2026年） Market Analysis and Insights: Global Serotonin Antagonists Market The global Serotonin Antagonists market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Serotonin Antagonists Scope and Market Size Serotonin Antagonists marke…
- オキシトシン受容体拮抗薬の世界市場（～2026年） Market Analysis and Insights: Global Oxytocin Receptor Antagonists Market The global Oxytocin Receptor Antagonists market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Oxytocin Receptor Antagonists Scope and Market Size Oxy…